PDPN and neoplasm: Eighteen cases (40%) showed podoplanin positivity in 31-50% of tumor cells, eleven cases (24%) showed positivity in51-80% of tumor cells, seven cases (16%) showed positivity in 1 – 10% of tumor cells, five cases (11%) showed positivity in 11-30% of tumor cells, and two cases (4%) showed positivity in >80% of tumor cells.